Statera BioPharma (STU:7CB) Other Operating Expense : €-3.42 Mil (TTM As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Other Operating Expense?

Statera BioPharma's Other Operating Expense for the three months ended in Sep. 2022 was €-0.68 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2022 was €-3.42 Mil.

Statera BioPharma's quarterly Other Operating Expense increased from Mar. 2022 (€-0.91 Mil) to Jun. 2022 (€-0.73 Mil) and increased from Jun. 2022 (€-0.73 Mil) to Sep. 2022 (€-0.68 Mil).

Statera BioPharma's annual Other Operating Expense declined from Dec. 2019 (€0.00 Mil) to Dec. 2020 (€0.00 Mil) and declined from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€-1.32 Mil).

Statera BioPharma Other Operating Expense Historical Data

The historical data trend for Statera BioPharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Other Operating Expense Chart

Statera BioPharma Annual Data

Trend

Dec19

Dec20

Dec21

Other Operating Expense

-1.32

Statera BioPharma Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Other Operating Expense	Get a 7-Day Free Trial						-0.20	-1.11	-0.91	-0.73	-0.68

Statera BioPharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.42 Mil.

Statera BioPharma Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Statera BioPharma (STU:7CB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525

Website

https://www.staterabiopharma.com

Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines